(E)-Trimethyl(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)prop-1-en-1-yl)silane, 98%, 250mg

DBD-CO-Hz [=4-(N,N-Dimethylaminosulfonyl)-7-(N-hydrazinocarbonylmethyl-N-methyl)amino-2,1,3-benzoxadiazole] [for HPLC Labeling]>98.0%(HPLC)100mg

2,5-Dichlorophenyl 2-ethoxyethylsulfide, 25g

1,2,4-Trihydroxybenzene, 95.0%, 1g

Ethyl 2,6-dichloro-5-fluoronicotinate, 98+%, 10g

2-(1-Methyl-1H-pyrazol-3-yl)-benzenesulfonamide, 95.0%, 1g

2-(2-(2-Methoxyethoxy)ethoxy)ethyl methanesulfonate, 97%, 5g

tert-Butyl 2-chloro-1H-benzo[d]imidazole-1-carboxylate, 95.0%, 5g

2-Chloro-5-(1-pyrrolidinyl)benzoic acid, 97%, 5g

2-Oxa-8-azaspiro[4.5]decane hydrochloride, 95.0%, 10g

1-Naphthoyl cyanide, 98%, 25g

(4aS,7R,8aS)-9,9-Dimethyltetrahydro-4H-4a,7-methanobenzo[c][1,2]oxazireno[2,3-b]isothiazole 3,3-dioxide, 95.0%, 25g

2-Bromo-5-iodopyridin-4-amine, 98%, 100mg